Lipoprotein (a) Levels in childhood arterial ischemic stroke

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 2, 2010, Pages 214-217

  Teber, Serap ^a   Deda, Gülhis ^a   Akar, Nejat ^a   Soylu, Kazim ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Childhood ischemic stroke; Lipoprotein (a)

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; INFANT; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; VENOUS THROMBOEMBOLISM;

ADOLESCENT; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; ENCEPHALITIS; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERLIPIDEMIAS; INFANT; INFANT, NEWBORN; INFARCTION, MIDDLE CEREBRAL ARTERY; INFARCTION, POSTERIOR CEREBRAL ARTERY; LIPOPROTEIN(A); MALE; MOYAMOYA DISEASE; RECURRENCE; RISK FACTORS; TURKEY;

EID: 77949878595     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609334124     Document Type: Article

References (20)

1. Schoenberg BS, Mellinger JF, Schoenberg DG Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978 ; 28 (8). 763-768.
2. Riela AR, Roach ES Etiology of stroke in children. J Child Neurol. 1993 ; 8 (3). 201-220.
3. Lynch JK, Hirtz DG, deVeber G., Nelson KB Report of the national institute of neurological disorders and stroke workshop on perinatal and childhood stroke. Pediatrics. 2002 ; 109 (1). 116-123.
4. Giroud M., Lemesle M., Gouyon JB, Nivelon JL, Milan C., Dumas R. Cerebrovascular disease in children under 16 years of age in Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995 ; 48 (11). 1343-1348.
5. Jordan LC Stroke in childhood. Neurologist. 2006 ; 12 (2). 94-102.
6. Akar N. Molecular approach to Turkish pediatric stroke patients. Turk J Hematol. 2002 ; 19 (2). 245-253.
7. Armstrong VW, Walli AK, Seidel D. Isolation, characterization and uptake in human fibroblasts of an apo (a)-free lipoprotein obtained on reduction of lipoprotein (a). J Lipid Res. 1985 ; 26 (11). 1314-1323.
8. Seman LJ, Breckenridge WC Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a). Biochem Cell Biol. 1986 ; 64 (10). 999-1009.
9. Caplice NM, Panetta C., Peterson TE, et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood. 2001 ; 98 (10). 2980-2987.
10. Rader DJ, Hoeg JM, Brewer HB Jr. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med. 1994 ; 120 (12). 1012-1015.
11. Maher VM, Brown BG Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol. 1995 ; 6 (4). 229-235.
12. Rosengren A., Wilhelmsen L., Eriksson E., Risberg B., Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case control study in a general population of middle-aged men. BMJ. 1990 ; 301 (6763). 1248-1251.
13. Nowak-Gottl U., Debus O., Findeisen M., et al. Lipoprotein (a): its role in childhood thromboembolism. Pediatrics. 1997 ; 99 (6). E11.
14. Jurgens G., Koltringer P. Lipoprotein (a) in ischemic cerebrovascular disease: a new approach to the assessment of risk of stroke. Neurology. 1987 ; 37 (3). 513-515.
15. Sträter R., Becker S., von Eckardstein A., et al. Prospective assessment of risk factors for recurrent stroke during childhood a 5-year follow-up study. Lancet. 2002 ;16; 360 (9345). 1540-1545.
16. Akar N. Site specific mutagenesis: usage for the mutation detection in thrombosis. Turk J Haematol. 1998 ; 15 (3). 123-124.
17. Nowak-Gottl U., Strater R., Heinecke A., et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999 ; 94 (11). 3678-3682.
18. Nowak-Gottl U., Junker R., Hartmeier M., et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation. 1999 ; 100 (7). 743-748.
19. GözdaÅolu S., Uysal Z., Ertem M., Akar N. Three risk factors-high lipoprotein (a), elevated FVIII, and FV Leiden-in a pediatric Behçets disease patient with deep vein thrombosis. Thromb Res. 2002 ; 106 (4-5). 263.
20. Gürbüz O., Ozdemir Y., CoÅar CB, Kural G. Lipoprotein (a) in Behçets disease as an indicator of disease activity and in thrombotic complications. Eur J Ophthalmol. 2001 ; 11 (1). 62-65.